ClinicalTrials.gg
Not yet recruitingNCT07067411Updated Jul 16, 2025

Gamified Education for Diabetes Self-Management in GDM

An interventional study of Education Program Using Gamification on GDM in Gestational Diabetes Mellitus (GDM), sponsored by Yeditepe University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2025-07-16.

Sponsored by Yeditepe University · Not applicable, Interventional, and Supportive care

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
78
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 52 studies in Diabetes, Gestational with a site in Turkey — 9 open to participants now, 12 under way, none of them phase 3. Diabetes, Gestational · Turkey.

Planned enrollment
16th of 28
78 · median 85
Started
2025
with 6 others
No phase
28 of 52
5 open now
Primary completion
2027-07
later than 9 of 11 live
Registered
41st of 52
by date

Among the 52 studies in Diabetes, Gestational with a site in Turkey, this one is the 16th largest by planned enrollment of the 28 interventional ones that give a count, is one of 7 that started in 2025, is one of 28 with no phase, reaches primary completion later than 9 of the 11 other live ones, and was the 41st registered.

Diabetes, Gestational

878 studies on the registry are indexed under Diabetes, Gestational; 196 are open to participants now.

Browse Diabetes, Gestational studies →

Open to participants now

9 of the 52 studies in Diabetes, Gestational with a site in Turkey are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 132 Diabetes, Gestational studies recruiting now, 60 (45%) set no upper age limit and 70 (53%) stop at 75 or younger; 12 take children under 18; 60 take healthy volunteers.

This study: 18 Years to 40 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 52 studies in Diabetes, Gestational with a site in Turkey, or all of them as a file.
02

Study summary

Gestational diabetes mellitus (GDM) is a serious public health problem characterized by hyperglycemia that develops during pregnancy and causes significant short- and long-term health risks for both the mother and the fetus. Lifestyle changes, especially appropriate diet and exercise practices and glycemic control are among the basic approaches in GDM management. However, the individual's adoption and sustainability of these approaches are often insufficient, and the individual's participation in treatment and motivation levels may be limited.

When the literature is examined, it has been proven that gamification-based interventions, especially in individuals with type 2 diabetes, have positive effects such as increasing the level of knowledge, encouraging physical activity and improving glycemic control. However, the lack of gamification-based nursing interventions specific to women with GDM is striking. The fact that there is no standardized nursing protocol specific to GDM management in our country makes the literature gap in this area even more evident.

This study aims to develop health behaviors in individuals with GDM through a gamified training program to be developed based on the Information-Motivation-Behavioral Skills (IMB) model. Thanks to the innovative structure of gamification, it is aimed not only to increase the knowledge level of individuals, but also to increase their motivation and make behavioral changes permanent. Thus, the active participation of the individual in the treatment process will be encouraged and the self- management skills will be strengthened.

This research will be an important step in terms of the integration of digitalization and patient-centered approaches in nursing practices, as well as indirectly contributing to the protection and development of public health. While the training program has the potential to increase the quality of life at the individual level, it will also allow the development of an original and structured nursing care intervention that can be used in GDM management.

This study aims to fill an important gap in the literature, to disseminate innovative practices in the field of nursing, and to support healthy pregnancy outcomes at the social level. For this reason, the purpose of the research was planned to examine the effect of the training program applied to women with gestational diabetes with the gamification technique based on the information-motivation-behavior (IMB) model on diabetes self-management.

03

Conditions studied

  • Gestational Diabetes Mellitus (GDM)

Browse trials for

Keywords

  • gestational diabetes
  • self-management
  • gamification
  • nursing
04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Those who speak Turkish,
  • Literate,
  • Between the ages of 18 and 40,
  • Those diagnosed with Gestational Diabetes Mellitus (based on a single-stage and/or two-stage oral glucose tolerance test between the 24th and 28th weeks),
  • Those with a singleton pregnancy,
  • Pregnant women who have not been previously diagnosed with diabetes,
  • Those who do not have a chronic disease diagnosed by a doctor (hypertension, cardiovascular diseases, kidney diseases, anemia, thyroid and diseases),
  • Those who do not have any other pregnancy-related problems (gestational hypertension, preeclampsia, gestational thyroiditis, etc.),
  • Those who do not have a physical disability,
  • Pregnant women who have access to the internet via phone or computer will be included in the sample.

Exclusion criteria

Exclusion Criteria:

  • Those who cannot read or write,
  • Those with threatened premature labor (PTD), premature membrane rupture (PROM), preeclampsia; risky pregnancy conditions,
  • Intrauterine mortal fetus,
  • Those who have experienced significant losses in the last 3 months (divorce, death of a loved one, etc.),
  • Those with moderate to severe (over 14 points) depressive symptoms as a result of the Patient Health Questionnaire-8 (PHQ-8) will be considered as a risk group and will not be included in the sample.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
78 participants (estimated)

Study arms

  • Experimental
    The group participating in the Education Program Given with Gamification Technique

    39 participants were assigned as a result of randomization. Participants receiving care through games.

    Behavioral: Education Program Using Gamification on GDM

  • No intervention
    Control

    39 participants were assigned as a result of randomization. Receiving only routine care.

Interventions

  • BehavioralEducation Program Using Gamification on GDM

    The five games planned to be used in the study are; "What is Gestational Diabetes?", "Nutrition Education", "Complication Precautions", "Medical Treatment Applications" and "Physical Activity". The creation and implementation of these games will be done through the "Genially" platform. The Genially platform is an easy-to-use and free web tool used to create interactive visual content. The platform includes features such as sharing or downloading via website, social media or e-mail by adding animations, effects, sounds and interactive elements. In addition, the performances of the people who share the created content can be tracked and feedback can be obtained. At the beginning of the games planned to be used in the study, an informative video of not more than five minutes on the subject created by the researcher will be shared. National and international guidelines will be taken into consideration in the creation of these videos. One day after the informative video is

06

What researchers measure

Primary outcomes

  1. Self-Efficacy Scale in Gestational Diabetes

    The validity and reliability of the "Self-Efficacy Scale in Gestational Diabetes" was determined by Polat and Ünsal Avdal and it was concluded that it is a valid and reliable measurement tool. The Self-Efficacy Scale in Gestational Diabetes (SESGD) is a five-point Likert-type scale consisting of four sub-dimensions. The sub-dimensions of the scale are; ''Diet-Weight Management'', ''Complication Precautions'', ''Adherence to Nutrition Education'' and ''Medical Treatment Applications''. The total Cronbach alpha value of the scale was determined as 0.654. The scale includes positive and negative statements. Reverse and forward coding is done during the analysis. It can be thought that as the score to be obtained from the scale increases as a result of the coding of positive and negative statements in the scale, the individual's self-efficacy will increase and that he/she will be able to effectively take care of himself/herself as a result of the education he/she receives.

    Time frame: through study completion, an average of 1 year

Other outcomes

  1. International Physical Activity Questionnaire Short Form-Turkish version (IPAQ)

    For the analysis of IPAQ data, it is evaluated as "walking: 3.3 MET", "moderate physical activity: 4.0 MET", "vigorous physical activity: 8.0 MET". Daily and weekly physical activity levels are calculated using these values. As the MET value increases, the physical activity level increases.

    Time frame: through study completion, an average of 1 year

07

Study locations

1 site
  • Zeynep Kamil Women and Children Diseases Traning and Research Hospital
    Istanbul, Uskudar 34668, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2025; primary completion for Jul 2027, 23 months later.

Of 306 non-industry interventional studies with no phase under Diabetes, Gestational, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 48. This study's planned 23 months is below that.

Counting every sponsor, half of 309 studies reached it within 28 months; a quarter within 13 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 2, 2025
First posted
Jul 16, 2025
StartEst.
Jul 15, 2025
Primary completionEst.
Jul 1, 2027
CompletionEst.
Jul 1, 2027
Last update
Jul 16, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 16, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07067411
Responsible party
Begum Kirik (Lecturer, Yeditepe University) — Principal investigator
First posted
Jul 16, 2025
Start date
Jul 15, 2025 (estimated)
Primary completion
Jul 1, 2027 (estimated)
Completion
Jul 1, 2027 (estimated)
Last update
Jul 16, 2025

Study contacts

Begüm Kırık
Contact
begum.kirik@yeditepe.edu.tr
+905454369290

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion